Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1000275 TORONTO, A6
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,677
-$1,902 QoQ
Shares Held
4,252
+12.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 101 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. INO ranks #324 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in INO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,677 4,252
2026-03-31 $6,579 3,782
2025-12-31 $2,937 1,689
2025-09-30 $387,222 165,480
2025-06-30 $249,414 122,263
2025-03-31 $7,185 4,409
2024-12-31 $20,257 11,070
2024-09-30 $21,292 3,684
2024-06-30 $28,287 3,501
2024-03-31 $15,850 1,142
2023-12-31 $37,699 73,923
2023-09-30 $30,325 77,760
2023-06-30 $6,560 14,583
2023-03-31 $23,273 28,384
2022-12-31 $569,756 365,230
2022-09-30 $99,709 57,636
2022-06-30 $55,751 32,227
2022-03-31 $162,776 45,342
2021-12-31 $749,575 150,216
2021-09-30 $504,398 70,447
2021-06-30 $479,710 51,749
2021-03-31 $443,081 47,746
2020-12-31 $219,167 24,765
2020-09-30 $200,087 17,249
2020-06-30 $574,492 21,317
2020-03-31 $220,729 29,668